Skip to content
Luna Metabolic
Menu

Head-to-head for women

REMEVi vs Effecty

REMEVi and Effecty both offer GLP-1 telehealth to women, but they make different trade-offs on PCOS and hormonal suitability, clinical oversight, price and access. Here they are side-by-side on the Luna Fit Score — our women's-health rubric.

REMEVi

Ranked #17 for women · Grade B

Best for: Women who prioritize LegitScript accreditation and nationwide access, and don't mind mid-to-higher pricing.

Visit REMEVi
vs

Effecty

Higher score

Ranked #6 for women · Grade B+

Best for: Women who want the flexibility of both compounded and FDA-approved brand medication from a LegitScript-accredited, nationwide provider.

Visit Effecty

The verdict for women

Higher Luna Fit Score: Effecty

Effecty edges out REMEVi on the Luna Fit Score, 87 to 85 (B+ vs B). Women who want the flexibility of both compounded and FDA-approved brand medication from a LegitScript-accredited, nationwide provider.

REMEVi is still a genuine option — an accredited nationwide program with both molecules — solid oversight, though pricing sits toward the higher end. Weigh the six women's-health factors below against your own priorities.

Side-by-side on the six factors

Both providers scored on the same women's-health rubric — the higher side on each factor is marked. See the methodology.

REMEVi Effecty
PCOS & hormonal suitability8386
REMEVi
Effecty
Clinical oversight & labs8588
REMEVi
Effecty
Price transparency8285
REMEVi
Effecty
Nationwide access9595
REMEVi
Effecty
Ongoing support8384
REMEVi
Effecty
Cancellation fairness8283
REMEVi
Effecty

Price, access & features

DetailREMEViEffecty
Luna Fit Score85/100 · B87/100 · B+
Overall rank#17#6
Semaglutide$199/mo$160/mo
Tirzepatide$269/mo$240/mo
CoverageAll 50 statesAll 50 states
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyInjection only

REMEVi

Ranked #17 · Grade B

What we like

  • LegitScript-accredited and available in all 50 states
  • Both molecules disclosed, tirzepatide for insulin-resistant PCOS
  • Clear, predictable pricing

The caveats

  • Higher-end pricing — $199 semaglutide, $269 tirzepatide
  • No oral or brand-name option; general program without hormone specialization

Effecty

Ranked #6 · Grade B+

What we like

  • FDA-approved brand access plus compounded, both molecules
  • LegitScript-accredited — a meaningful oversight signal when hormones are involved
  • Nationwide across all 50 states

The caveats

  • No oral/sublingual form
  • Not a hormone-specialty program; PCOS framing is general

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Luna Fit Score. Pricing, states and verification reflect each provider's public disclosures at last review; the Luna Fit Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

More head-to-heads

Keep comparing REMEVi and Effecty against other providers we review for women.

Or browse the full comparison hub.